ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,795Medicare Part D Prescriptions Filled, Including Refills

Rank: 200 out of 761

$367K Total Retail Price of All Prescriptions

Rank: 244 out of 761

441 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 441 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

15% of this provider’s 441 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 6,446 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LEVOTHYROXINE SODIUM 386 346 1 3
LISINOPRIL 329 294 2 1
SIMVASTATIN 233 209 3 2
ATENOLOL 221 176 4 8
HYDROCODONE-ACETAMINOPHEN 215 166 S3 5 5
FUROSEMIDE 212 196 6 7
AMLODIPINE BESYLATE 202 181 7 6
CITALOPRAM HBR 189 180 8 19
OMEPRAZOLE 177 125 9 4
WARFARIN SODIUM 149 137 10 9
GABAPENTIN 131 106 11 15
POTASSIUM CHLORIDE 129 110 12 18
HYDROCHLOROTHIAZIDE 127 106 13 11
METFORMIN HCL 126 83 14 10
FLUOXETINE HCL 122 85 15 31
SERTRALINE HCL 121 111 16 25
LOVASTATIN 118 108 17 17
NAMENDA 100 100 18 59
TRAZODONE HCL 100 82 18 23
CYCLOBENZAPRINE HCL 96 51 R 20 51
ZOLPIDEM TARTRATE 93 79 21 22
DONEPEZIL HCL 93 93 21 33
FLUTICASONE PROPIONATE 91 66 23 29
METOPROLOL TARTRATE 87 75 24 14
LANTUS 82 81 25 41
PRAVASTATIN SODIUM 81 71 26 20
OXYCODONE HCL 81 48 S2 26 24
ATORVASTATIN CALCIUM 80 74 28 12
LOSARTAN POTASSIUM 75 64 29 13
TRAMADOL HCL 73 72 30 34
OXYCODONE-ACETAMINOPHEN 73 35 S2 30 49
ALENDRONATE SODIUM 70 69 32 21
ADVAIR DISKUS 65 57 33 37
TRIAMTERENE-HCTZ 62 54 34 42
DIOVAN 60 49 35 58
GLIPIZIDE 59 51 36 39
CIPROFLOXACIN HCL 55 50 37 63
METOPROLOL SUCCINATE 54 53 38 16
CARVEDILOL 54 50 38 26
TRIAMCINOLONE ACETONIDE 50 34 40 84
LYRICA 50 15 40 134
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.